You are here

NZUMBE INC

Company Information
Address
4023 NE HANCOCK ST
PORTLAND, OR 97212-5324
United States



Information

UEI: NSVYJ517CHC5

# of Employees: 3


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Using epigenetic science to improve environmental health literacy

    Amount: $649,748.00

    Project Summary NIEHS defines environmental health as “the field of science that studies how the environment influences human health and disease”. The environment in this definition includes the n ...

    SBIRPhase II2023Department of Health and Human Services National Institutes of Health
  2. Targeting distinct DNA methylation signatures in pediatric glioma using HITMA

    Amount: $355,000.00

    Pediatric high-grade gliomas (pHGG) have proven to be extremely difficult to treat with a dismal survival rate. Fresh, innovative therapeutic approaches are desperately needed to combat this devastati ...

    SBIRPhase I2022Department of Health and Human Services National Institutes of Health
  3. Using epigenetic science to improve environmental health literacy

    Amount: $225,000.00

    Project Summary/Abstract NIEHS defines environmental health as “the field of science that studies how the environment influences human health and disease”. The environment in this definition inclu ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  4. NeuroPredict, A screening assay for chemicals that affect the differentiation of human neural cells.

    Amount: $1,497,446.00

    ABSTRACT A growing human health concern is that exposure to chemicals in our environment harms the highly vulnerable period of human brain developmentIndeedincreasing evidence shows that even simpleac ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  5. A screening assay for chemicals that affect the differentiation of human neural cells.

    Amount: $224,985.00

    DESCRIPTION provided by applicant Human brain development represents a highly vulnerable time to chemical exposures because immature cells are actively undergoing differentiation into more complex ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  6. Rapid Screening Assay for Novel Epigenetic Drugs

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): A hallmark of virtually every cancer is aberrant epigenetic silencing of vital genes required for a normal cell cycle and genome stability (e.g. MLH1, BRCA1, VHL, ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government